Chinese Journal of Tissue Engineering Research ›› 2016, Vol. 20 ›› Issue (43): 6416-6423.doi: 10.3969/j.issn.2095-4344.2016.43.005

Previous Articles     Next Articles

Titanium dioxide nanotube composite coating: preparation and early drug-release

Wang Fei-fan1, Song Yun-jia1, Wu Wen-meng1, 2, Lv Wu-long1, Li Ying1, Li Chang-yi1
  

  1. 1School of Stomatology, Tianjin Medical University, Tianjin 300070, China; 2Taiping Medical University of Vietnam, Taiping 33000, Vietnam
  • Received:2016-07-23 Online:2016-10-21 Published:2016-10-21
  • Contact: Li Ying, M.D., Associate chief physician, School of Stomatology, Tianjin Medical University, Tianjin 300070, China
  • About author:Wang Fei-fan, Studying for master’s degree, School of Stomatology, Tianjin Medical University, Tianjin 300070, China
  • Supported by:
    the National Natural Science Foundation of China, No. 31470920, 81500886; the Natural Science Foundation of Tianjin, No. 16JCYBJC28700

Abstract:

BACKGROUND: The surface modification of pure titanium has become a hotspot for research on improving the early implant-osseointegration ability.
OBJECTIVE: To construct the icariin/TiO2 nanotube composite coating, and to explore its drug-loading rate and early drug-release kinetics.
METHODS: Pure titanium was anodized to obtain TiO2 nanotube. Thereafter, the pure titanium and TiO2 nanotube were characterized by scanning electron microscopy, atomic force microscopy and contact angle instrument. Icariin was loaded onto the pure titanium and TiO2 nanotube by immersion method. Afterwards, the early drug-releasing amount of the two materials was measured using high-performance liquid chromatography. Accumulated release and accumulated drug-release percentage curves were drawn.
RESULTS AND CONCLUSION: The diameter of TiO2 nanotube was 80 nm, and the roughness of TiO2 nanotube was significantly higher than that of pure titanium (P < 0.05), but the contact angle was significantly lower than that of pure titanium (P < 0.05). Moreover, compared with the icariin/pure titanium group, the icariin/TiO2 nanotube group had obviously higher accumulated drug-releasing amount at former 14 days and accumulated drug-releasing carve at former 4 hours. The accumulated drug-releasing percentage curve in the icariin/TiO2 nanotube group was flatter than that in the icariin/pure titanium group, suggesting a longer release time. To conclude, the icariin/TiO2 nanotube composite coating has a higher drug, loading and exerts better sustained-release effect.

Key words: Titanium, Nanotubes, Synostosis, Tissue Engineering

CLC Number: